About DZNE
DZNE is a Healthcare company based in Bonn (Germany). Neurodegenerative diseases are researched and therapies are developed. It operates on a Research and Development model. Its website dzne.de draws about 105 thousand monthly visits. DZNE offers products and services including Neurodegenerative Disease Research and Clinical Studies. Its focus areas include Medical Research and Neurodegenerative Diseases. Its legal entity is Deutsches Zentrum für Neurodegenerative Erkrankungen.
Company details
Research on neurodegenerative diseases such as Alzheimers, Parkinsons, ALS, and various forms of dementia is carried out by the DZNE. Solutions for early detection, innovative therapies, and improved treatments are developed through fundamental, clinical, and population-based research. Sectors including healthcare and medical technology are served through collaborations, technology transfer, and scientific projects.
- Headquarters Bonn, Germany
- SectorsHealthcare
- Phone•••• ••••
- Website dzne.de
- Legal Name Deutsches Zentrum Für Neurodegenerative Erkrankungen
- Latest Funding Round$159.54K (USD), Grant
Jun 2022
- Investors
Products & Services of DZNE
DZNE offers a comprehensive portfolio of products and services, including Neurodegenerative Disease Research and Clinical Studies.
Research focused on understanding, decoding causes, and developing therapies for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS is conducted.
Clinical studies involving participants for early detection and treatment research of neurodegenerative diseases are facilitated.
Funding Insights of DZNE
- Total Rounds 23
- Last Round Grant — $159,539
- First Round $3M
(May 2014)
- Investors Count 1
Latest 10 of 23 funding rounds of DZNE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $159,539 | Grant | – | – | |
| Dec 2021 | $2.27M | Grant | – | – | |
| Jan 2021 | $795,608 | Grant | – | – | |
| Sep 2020 | $208,419 | Grant | – | – | |
| Apr 2020 | $985,597 | Grant | – | – | |
| Apr 2020 | $985,597 | Grant | – | – | – |
| Mar 2020 | $165,782 | Grant | – | – | |
| Aug 2019 | $1.63M | Grant | – | – | |
| May 2019 | $566,269 | Grant | – | – | |
| Mar 2019 | $1.71M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in DZNE
DZNE has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for DZNE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DZNE
110 people are tracked at DZNE (8 in leadership, 102 in team).
| Name | Role | Group |
|---|---|---|
Pierluigi Nicotera | Scientific Director and Chairman | Leadership |
Alexander Dityatev | Head Of The Molecular Neuroplasticity Group | Leadership |
Uta Strasser | Head Of Grant Office | Leadership |
Lars Krüger | Head Of Technology Transfer | Leadership |
Sabina Tahirovic | Head Of Juvenile Neurodegeneration Group | Leadership |
Cristina Amparo Hagmann | Head Of Biorepository | Leadership |
Tonatiuh Pena Centeno | Head Of Bioinformatics Core Unit | Leadership |
Philip Denner | Head Of Laboratory Automation Technologies LAT | Leadership |
Dr. Birgit Morherr | Lab Manager | Team |
Eren Diniz | Doctoral Researcher | Team |
Christian Ewert | Research Assistant | Team |
Dr. Tanja M. Weber | Lab Manager | Team |
Danilo Prtvar | Main Phd Representative | Team |
Andreas Husch | Postdoctoral Researcher | Team |
Lars Paeger | Leader Of In Vivo Electrophysiolgy Lab | Team |
Heba Ali | Postdoctoral Researcher | Team |
Riccardo Leone | Guest Researcher | Team |
Bernhard Michalowsky | Working Group Leader - "patient-reported Outcomes & Health Economics Research" | Team |
Cemil Kerimoglu | Senior Research Scientist | Team |
Alberto Arboit | Postdoctoral Researcher | Team |
90 more people are available in the full profile.
Complete people profiles for DZNE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DZNE
2 dated milestones of DZNE across 8 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Grant, of $160K.
Web traffic of DZNE
The website of DZNE (dzne.de) receives about 105K visits a month.
- Monthly visits105K
▲ 14.8% vs previous month
Websites whose visitors overlap most with DZNE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mdc-berlin.de | 100% | 144.6K | #230,099 | View details | |
digs-bb.de | digs-bb.de | 97% | – | ||
cnprc.ucdavis.edu | cnprc.ucdavis.edu | 94% | – | ||
dpz.gwdg.de | dpz.gwdg.de | 94% | – | ||
| hms.harvard.edu | 94% | 1.8M | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for DZNE
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DZNE
DZNE is headquartered in Bonn, Germany. It is registered at Bonn, North Rhine-westphalia, Germany.
Research on neurodegenerative diseases such as Alzheimers, Parkinsons, ALS, and various forms of dementia is carried out by the DZNE. Solutions for early detection, innovative therapies, and improved treatments are developed through fundamental, clinical, and population-based research. Sectors including healthcare and medical technology are served through collaborations, technology transfer, and scientific projects.
DZNE offers Neurodegenerative Disease Research and Clinical Studies.
DZNE has 1 investor. Key investors include European Union.
DZNE operates through Deutsches Zentrum Für Neurodegenerative Erkrankungen.
The website of DZNE receives about 105 thousand visits a month.